PMC:7696151 / 15947-16184 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"468","span":{"begin":98,"end":101},"obj":"Chemical"},{"id":"469","span":{"begin":218,"end":221},"obj":"Chemical"}],"attributes":[{"id":"A468","pred":"tao:has_database_id","subj":"468","obj":"MESH:D006886"},{"id":"A469","pred":"tao:has_database_id","subj":"469","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e naïve to HAART or had stopped this therapy 22 months before the trial began; 17 subjects in the HCQ group and 8 in the placebo group interrupted study medication before the 48th week. At the end of treatment, in the HCQ group, compared"}